— Know what they know.
Not Investment Advice

KRYS NASDAQ

Krystal Biotech, Inc.
1W: -3.8% 1M: +10.2% 3M: +16.2% YTD: +23.2% 1Y: +131.3% 3Y: +243.6% 5Y: +347.9%
$299.45
-4.78 (-1.57%)
 
Weekly Expected Move ±5.7%
$271 $289 $306 $324 $341
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 67 · $8.8B mcap · 23M float · 1.21% daily turnover · Short 81% of daily vol

📊 Key Metrics

TTM
$417M
Revenue
+25.1% YoY
$225M
Net Income
+81.5% YoY
$237M
Free Cash Flow
+83.6% YoY
94.6%
Gross Margin
46.1%
Op. Margin
48.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE20.8%
ROA18.8%
ROIC48.4%

Valuation

P/E39.0
P/B6.9
EV/EBITDA38.1

Leverage

Debt/Equity0.01
Current Ratio9.95
Interest Cov.0.0x

Quality Scores

Piotroski F8/9
Altman Z43.00
Beneish M-2.37

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms